title: Liraglutide treatment in a patient with HIV, type 2 diabetes and sleep apnoea-hypopnoea syndrome.
authors.affiliation: Department of Internal Medicine, Marbella, Málaga, Spain. Electronic address: gdelucaslola@gmail.com.
authors.forename: M D
authors.initials: MD
authors.lastname: García de Lucas
authors.affiliation: Department of Internal Medicine, Marbella, Málaga, Spain. Electronic address: julio.olalla@gmail.com.
authors.forename: J
authors.initials: J
authors.lastname: Olalla Sierra
authors.affiliation: Department of Pneumology, Hospital Costa del Sol, Marbella, Málaga, Spain. Electronic address: juanapf@me.com.
authors.forename: J
authors.initials: J
authors.lastname: Piña Fernández
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy*; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000069450:Liraglutide; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications*; D020181:Sleep Apnea, Obstructive / Q000150:complications*; D015431:Weight Loss
chemical_list: D007004:Hypoglycemic Agents; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1
keywords: Apnoea–hypopnoea index, Liraglutide; HIV; Obesity; Sleep apnoea–hypopnoea syndrome; Type 2 diabetes mellitus